nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—Interstitial lung disease—Etoposide—muscle cancer	0.0203	0.0203	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Dactinomycin—muscle cancer	0.0133	0.0133	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.013	0.013	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Vincristine—muscle cancer	0.0129	0.0129	CcSEcCtD
Desvenlafaxine—Urinary retention—Vincristine—muscle cancer	0.0122	0.0122	CcSEcCtD
Desvenlafaxine—Interstitial lung disease—Methotrexate—muscle cancer	0.0122	0.0122	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.011	0.011	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Vincristine—muscle cancer	0.0103	0.0103	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Vincristine—muscle cancer	0.0102	0.0102	CcSEcCtD
Desvenlafaxine—Weight decreased—Vincristine—muscle cancer	0.0101	0.0101	CcSEcCtD
Desvenlafaxine—Proteinuria—Methotrexate—muscle cancer	0.0098	0.0098	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Vincristine—muscle cancer	0.00978	0.00978	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Vincristine—muscle cancer	0.00973	0.00973	CcSEcCtD
Desvenlafaxine—Protein urine present—Methotrexate—muscle cancer	0.00966	0.00966	CcSEcCtD
Desvenlafaxine—Musculoskeletal stiffness—Methotrexate—muscle cancer	0.0096	0.0096	CcSEcCtD
Desvenlafaxine—Bone disorder—Methotrexate—muscle cancer	0.00953	0.00953	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Dactinomycin—muscle cancer	0.00943	0.00943	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00939	0.00939	CcSEcCtD
Desvenlafaxine—Chills—Dactinomycin—muscle cancer	0.00895	0.00895	CcSEcCtD
Desvenlafaxine—Hallucination—Vincristine—muscle cancer	0.00886	0.00886	CcSEcCtD
Desvenlafaxine—Alopecia—Dactinomycin—muscle cancer	0.00881	0.00881	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Vincristine—muscle cancer	0.0088	0.0088	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Vincristine—muscle cancer	0.00876	0.00876	CcSEcCtD
Desvenlafaxine—Urethral disorder—Vincristine—muscle cancer	0.00873	0.00873	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Vincristine—muscle cancer	0.00827	0.00827	CcSEcCtD
Desvenlafaxine—Bone disorder—Doxorubicin—muscle cancer	0.00825	0.00825	CcSEcCtD
Desvenlafaxine—Angiopathy—Vincristine—muscle cancer	0.00808	0.00808	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Vincristine—muscle cancer	0.00803	0.00803	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00797	0.00797	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Etoposide—muscle cancer	0.00793	0.00793	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Etoposide—muscle cancer	0.00788	0.00788	CcSEcCtD
Desvenlafaxine—Alopecia—Vincristine—muscle cancer	0.00787	0.00787	CcSEcCtD
Desvenlafaxine—Mental disorder—Vincristine—muscle cancer	0.00781	0.00781	CcSEcCtD
Desvenlafaxine—Abnormal dreams—Doxorubicin—muscle cancer	0.00737	0.00737	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Etoposide—muscle cancer	0.00713	0.00713	CcSEcCtD
Desvenlafaxine—Urethral disorder—Etoposide—muscle cancer	0.00707	0.00707	CcSEcCtD
Desvenlafaxine—Vertigo—Vincristine—muscle cancer	0.00697	0.00697	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Etoposide—muscle cancer	0.00682	0.00682	CcSEcCtD
Desvenlafaxine—Eye disorder—Etoposide—muscle cancer	0.00674	0.00674	CcSEcCtD
Desvenlafaxine—Convulsion—Vincristine—muscle cancer	0.00672	0.00672	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Etoposide—muscle cancer	0.0067	0.0067	CcSEcCtD
Desvenlafaxine—Hypertension—Vincristine—muscle cancer	0.0067	0.0067	CcSEcCtD
Desvenlafaxine—Angiopathy—Etoposide—muscle cancer	0.00655	0.00655	CcSEcCtD
Desvenlafaxine—Immune system disorder—Etoposide—muscle cancer	0.00652	0.00652	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Etoposide—muscle cancer	0.0065	0.0065	CcSEcCtD
Desvenlafaxine—Chills—Etoposide—muscle cancer	0.00648	0.00648	CcSEcCtD
Desvenlafaxine—Alopecia—Etoposide—muscle cancer	0.00638	0.00638	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Vincristine—muscle cancer	0.00621	0.00621	CcSEcCtD
Desvenlafaxine—Decreased appetite—Dactinomycin—muscle cancer	0.00616	0.00616	CcSEcCtD
Desvenlafaxine—Dysgeusia—Etoposide—muscle cancer	0.00615	0.00615	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Vincristine—muscle cancer	0.00612	0.00612	CcSEcCtD
Desvenlafaxine—Fatigue—Dactinomycin—muscle cancer	0.00611	0.00611	CcSEcCtD
Desvenlafaxine—Irritability—Methotrexate—muscle cancer	0.00596	0.00596	CcSEcCtD
Desvenlafaxine—Hot flush—Doxorubicin—muscle cancer	0.00578	0.00578	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Methotrexate—muscle cancer	0.00577	0.00577	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Doxorubicin—muscle cancer	0.00573	0.00573	CcSEcCtD
Desvenlafaxine—Insomnia—Vincristine—muscle cancer	0.00573	0.00573	CcSEcCtD
Desvenlafaxine—Paraesthesia—Vincristine—muscle cancer	0.00568	0.00568	CcSEcCtD
Desvenlafaxine—Breast disorder—Methotrexate—muscle cancer	0.00565	0.00565	CcSEcCtD
Desvenlafaxine—Vertigo—Etoposide—muscle cancer	0.00564	0.00564	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00563	0.00563	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Etoposide—muscle cancer	0.00552	0.00552	CcSEcCtD
Desvenlafaxine—Decreased appetite—Vincristine—muscle cancer	0.0055	0.0055	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00546	0.00546	CcSEcCtD
Desvenlafaxine—Fatigue—Vincristine—muscle cancer	0.00546	0.00546	CcSEcCtD
Desvenlafaxine—Convulsion—Etoposide—muscle cancer	0.00544	0.00544	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Doxorubicin—muscle cancer	0.00543	0.00543	CcSEcCtD
Desvenlafaxine—Hypertension—Etoposide—muscle cancer	0.00542	0.00542	CcSEcCtD
Desvenlafaxine—Constipation—Vincristine—muscle cancer	0.00541	0.00541	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00541	0.00541	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00531	0.00531	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Dactinomycin—muscle cancer	0.00522	0.00522	CcSEcCtD
Desvenlafaxine—Asthenia—Dactinomycin—muscle cancer	0.00508	0.00508	CcSEcCtD
Desvenlafaxine—Tachycardia—Etoposide—muscle cancer	0.005	0.005	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Doxorubicin—muscle cancer	0.005	0.005	CcSEcCtD
Desvenlafaxine—Skin disorder—Etoposide—muscle cancer	0.00498	0.00498	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Methotrexate—muscle cancer	0.00497	0.00497	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Etoposide—muscle cancer	0.00496	0.00496	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00494	0.00494	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Methotrexate—muscle cancer	0.00493	0.00493	CcSEcCtD
Desvenlafaxine—Breast disorder—Doxorubicin—muscle cancer	0.00489	0.00489	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00487	0.00487	CcSEcCtD
Desvenlafaxine—Diarrhoea—Dactinomycin—muscle cancer	0.00485	0.00485	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00477	0.00477	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Vincristine—muscle cancer	0.00466	0.00466	CcSEcCtD
Desvenlafaxine—Paraesthesia—Etoposide—muscle cancer	0.0046	0.0046	CcSEcCtD
Desvenlafaxine—Somnolence—Etoposide—muscle cancer	0.00456	0.00456	CcSEcCtD
Desvenlafaxine—Epistaxis—Methotrexate—muscle cancer	0.00454	0.00454	CcSEcCtD
Desvenlafaxine—Asthenia—Vincristine—muscle cancer	0.00454	0.00454	CcSEcCtD
Desvenlafaxine—Vomiting—Dactinomycin—muscle cancer	0.0045	0.0045	CcSEcCtD
Desvenlafaxine—Rash—Dactinomycin—muscle cancer	0.00447	0.00447	CcSEcCtD
Desvenlafaxine—Decreased appetite—Etoposide—muscle cancer	0.00446	0.00446	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Etoposide—muscle cancer	0.00443	0.00443	CcSEcCtD
Desvenlafaxine—Fatigue—Etoposide—muscle cancer	0.00442	0.00442	CcSEcCtD
Desvenlafaxine—Constipation—Etoposide—muscle cancer	0.00438	0.00438	CcSEcCtD
Desvenlafaxine—Diarrhoea—Vincristine—muscle cancer	0.00433	0.00433	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Methotrexate—muscle cancer	0.00427	0.00427	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00427	0.00427	CcSEcCtD
Desvenlafaxine—Weight increased—Doxorubicin—muscle cancer	0.00426	0.00426	CcSEcCtD
Desvenlafaxine—Urethral disorder—Methotrexate—muscle cancer	0.00424	0.00424	CcSEcCtD
Desvenlafaxine—Weight decreased—Doxorubicin—muscle cancer	0.00423	0.00423	CcSEcCtD
Desvenlafaxine—Nausea—Dactinomycin—muscle cancer	0.00421	0.00421	CcSEcCtD
Desvenlafaxine—Dizziness—Vincristine—muscle cancer	0.00419	0.00419	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00413	0.00413	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Methotrexate—muscle cancer	0.00409	0.00409	CcSEcCtD
Desvenlafaxine—Eye disorder—Methotrexate—muscle cancer	0.00404	0.00404	CcSEcCtD
Desvenlafaxine—Tinnitus—Methotrexate—muscle cancer	0.00403	0.00403	CcSEcCtD
Desvenlafaxine—Vomiting—Vincristine—muscle cancer	0.00402	0.00402	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Methotrexate—muscle cancer	0.00401	0.00401	CcSEcCtD
Desvenlafaxine—Rash—Vincristine—muscle cancer	0.00399	0.00399	CcSEcCtD
Desvenlafaxine—Dermatitis—Vincristine—muscle cancer	0.00399	0.00399	CcSEcCtD
Desvenlafaxine—Headache—Vincristine—muscle cancer	0.00397	0.00397	CcSEcCtD
Desvenlafaxine—Epistaxis—Doxorubicin—muscle cancer	0.00393	0.00393	CcSEcCtD
Desvenlafaxine—Angiopathy—Methotrexate—muscle cancer	0.00392	0.00392	CcSEcCtD
Desvenlafaxine—Immune system disorder—Methotrexate—muscle cancer	0.0039	0.0039	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Methotrexate—muscle cancer	0.0039	0.0039	CcSEcCtD
Desvenlafaxine—Chills—Methotrexate—muscle cancer	0.00388	0.00388	CcSEcCtD
Desvenlafaxine—Alopecia—Methotrexate—muscle cancer	0.00382	0.00382	CcSEcCtD
Desvenlafaxine—Mental disorder—Methotrexate—muscle cancer	0.00379	0.00379	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Etoposide—muscle cancer	0.00378	0.00378	CcSEcCtD
Desvenlafaxine—Malnutrition—Methotrexate—muscle cancer	0.00376	0.00376	CcSEcCtD
Desvenlafaxine—Nausea—Vincristine—muscle cancer	0.00376	0.00376	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Doxorubicin—muscle cancer	0.0037	0.0037	CcSEcCtD
Desvenlafaxine—Dysgeusia—Methotrexate—muscle cancer	0.00369	0.00369	CcSEcCtD
Desvenlafaxine—Asthenia—Etoposide—muscle cancer	0.00368	0.00368	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Doxorubicin—muscle cancer	0.00368	0.00368	CcSEcCtD
Desvenlafaxine—Urethral disorder—Doxorubicin—muscle cancer	0.00367	0.00367	CcSEcCtD
Desvenlafaxine—Vision blurred—Methotrexate—muscle cancer	0.00355	0.00355	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Doxorubicin—muscle cancer	0.00354	0.00354	CcSEcCtD
Desvenlafaxine—Diarrhoea—Etoposide—muscle cancer	0.00351	0.00351	CcSEcCtD
Desvenlafaxine—Eye disorder—Doxorubicin—muscle cancer	0.0035	0.0035	CcSEcCtD
Desvenlafaxine—Tinnitus—Doxorubicin—muscle cancer	0.00349	0.00349	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Doxorubicin—muscle cancer	0.00347	0.00347	CcSEcCtD
Desvenlafaxine—Angiopathy—Doxorubicin—muscle cancer	0.0034	0.0034	CcSEcCtD
Desvenlafaxine—Dizziness—Etoposide—muscle cancer	0.00339	0.00339	CcSEcCtD
Desvenlafaxine—Immune system disorder—Doxorubicin—muscle cancer	0.00338	0.00338	CcSEcCtD
Desvenlafaxine—Vertigo—Methotrexate—muscle cancer	0.00338	0.00338	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Doxorubicin—muscle cancer	0.00337	0.00337	CcSEcCtD
Desvenlafaxine—Chills—Doxorubicin—muscle cancer	0.00336	0.00336	CcSEcCtD
Desvenlafaxine—Alopecia—Doxorubicin—muscle cancer	0.00331	0.00331	CcSEcCtD
Desvenlafaxine—Mental disorder—Doxorubicin—muscle cancer	0.00328	0.00328	CcSEcCtD
Desvenlafaxine—Convulsion—Methotrexate—muscle cancer	0.00326	0.00326	CcSEcCtD
Desvenlafaxine—Vomiting—Etoposide—muscle cancer	0.00326	0.00326	CcSEcCtD
Desvenlafaxine—Malnutrition—Doxorubicin—muscle cancer	0.00326	0.00326	CcSEcCtD
Desvenlafaxine—Rash—Etoposide—muscle cancer	0.00323	0.00323	CcSEcCtD
Desvenlafaxine—Dermatitis—Etoposide—muscle cancer	0.00323	0.00323	CcSEcCtD
Desvenlafaxine—Headache—Etoposide—muscle cancer	0.00321	0.00321	CcSEcCtD
Desvenlafaxine—Tension—Doxorubicin—muscle cancer	0.0032	0.0032	CcSEcCtD
Desvenlafaxine—Dysgeusia—Doxorubicin—muscle cancer	0.00319	0.00319	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00318	0.00318	CcSEcCtD
Desvenlafaxine—Nervousness—Doxorubicin—muscle cancer	0.00316	0.00316	CcSEcCtD
Desvenlafaxine—Vision blurred—Doxorubicin—muscle cancer	0.00307	0.00307	CcSEcCtD
Desvenlafaxine—Nausea—Etoposide—muscle cancer	0.00305	0.00305	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Methotrexate—muscle cancer	0.00301	0.00301	CcSEcCtD
Desvenlafaxine—Skin disorder—Methotrexate—muscle cancer	0.00298	0.00298	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Methotrexate—muscle cancer	0.00297	0.00297	CcSEcCtD
Desvenlafaxine—Vertigo—Doxorubicin—muscle cancer	0.00293	0.00293	CcSEcCtD
Desvenlafaxine—Syncope—Doxorubicin—muscle cancer	0.00292	0.00292	CcSEcCtD
Desvenlafaxine—Palpitations—Doxorubicin—muscle cancer	0.00288	0.00288	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Doxorubicin—muscle cancer	0.00286	0.00286	CcSEcCtD
Desvenlafaxine—Convulsion—Doxorubicin—muscle cancer	0.00282	0.00282	CcSEcCtD
Desvenlafaxine—Hypertension—Doxorubicin—muscle cancer	0.00281	0.00281	CcSEcCtD
Desvenlafaxine—Insomnia—Methotrexate—muscle cancer	0.00278	0.00278	CcSEcCtD
Desvenlafaxine—Anxiety—Doxorubicin—muscle cancer	0.00276	0.00276	CcSEcCtD
Desvenlafaxine—Paraesthesia—Methotrexate—muscle cancer	0.00276	0.00276	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00276	0.00276	CcSEcCtD
Desvenlafaxine—Somnolence—Methotrexate—muscle cancer	0.00273	0.00273	CcSEcCtD
Desvenlafaxine—Dry mouth—Doxorubicin—muscle cancer	0.00271	0.00271	CcSEcCtD
Desvenlafaxine—Decreased appetite—Methotrexate—muscle cancer	0.00267	0.00267	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00265	0.00265	CcSEcCtD
Desvenlafaxine—Fatigue—Methotrexate—muscle cancer	0.00265	0.00265	CcSEcCtD
Desvenlafaxine—Shock—Doxorubicin—muscle cancer	0.00262	0.00262	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Doxorubicin—muscle cancer	0.00261	0.00261	CcSEcCtD
Desvenlafaxine—Tachycardia—Doxorubicin—muscle cancer	0.0026	0.0026	CcSEcCtD
Desvenlafaxine—Skin disorder—Doxorubicin—muscle cancer	0.00258	0.00258	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Doxorubicin—muscle cancer	0.00257	0.00257	CcSEcCtD
Desvenlafaxine—Insomnia—Doxorubicin—muscle cancer	0.00241	0.00241	CcSEcCtD
Desvenlafaxine—Paraesthesia—Doxorubicin—muscle cancer	0.00239	0.00239	CcSEcCtD
Desvenlafaxine—Somnolence—Doxorubicin—muscle cancer	0.00236	0.00236	CcSEcCtD
Desvenlafaxine—Decreased appetite—Doxorubicin—muscle cancer	0.00231	0.00231	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.0023	0.0023	CcSEcCtD
Desvenlafaxine—Fatigue—Doxorubicin—muscle cancer	0.00229	0.00229	CcSEcCtD
Desvenlafaxine—Constipation—Doxorubicin—muscle cancer	0.00227	0.00227	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Methotrexate—muscle cancer	0.00226	0.00226	CcSEcCtD
Desvenlafaxine—Asthenia—Methotrexate—muscle cancer	0.0022	0.0022	CcSEcCtD
Desvenlafaxine—Diarrhoea—Methotrexate—muscle cancer	0.0021	0.0021	CcSEcCtD
Desvenlafaxine—Dizziness—Methotrexate—muscle cancer	0.00203	0.00203	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Doxorubicin—muscle cancer	0.00196	0.00196	CcSEcCtD
Desvenlafaxine—Vomiting—Methotrexate—muscle cancer	0.00195	0.00195	CcSEcCtD
Desvenlafaxine—Rash—Methotrexate—muscle cancer	0.00194	0.00194	CcSEcCtD
Desvenlafaxine—Dermatitis—Methotrexate—muscle cancer	0.00193	0.00193	CcSEcCtD
Desvenlafaxine—Headache—Methotrexate—muscle cancer	0.00192	0.00192	CcSEcCtD
Desvenlafaxine—Asthenia—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Desvenlafaxine—Nausea—Methotrexate—muscle cancer	0.00182	0.00182	CcSEcCtD
Desvenlafaxine—Diarrhoea—Doxorubicin—muscle cancer	0.00182	0.00182	CcSEcCtD
Desvenlafaxine—Dizziness—Doxorubicin—muscle cancer	0.00176	0.00176	CcSEcCtD
Desvenlafaxine—Vomiting—Doxorubicin—muscle cancer	0.00169	0.00169	CcSEcCtD
Desvenlafaxine—Rash—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Desvenlafaxine—Dermatitis—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Desvenlafaxine—Headache—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Desvenlafaxine—Nausea—Doxorubicin—muscle cancer	0.00158	0.00158	CcSEcCtD
